Karen Sweiss, PharmD¹, Jay R. Hydren, PhD², Jorge Arturo Hurtado Martinez, MD^2*, Mason S. Barnes, B.S.^2*, Pritesh Patel, MD^3*, Douglas W Sborov, MD⁴, Jennifer M. Ahlstrom, BA^2*, Lisa Sharp, PhD, BSN, MA^5* and Craig C. Hofmeister, MD⁶

¹Department of Pharmacy Practice, University of Illinois at Chicago, Hinsdale, IL
²HealthTree Foundation, Lehi, UT
³Division of Hematology/Oncology, University of Illinois at Chicago, Chicago, IL
⁴Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
⁵University of Illinois at Chicago, Chicago, IL
⁶Winship Cancer Institute of Emory University, Atlanta, GA

Anna Fleischer^1*, Mohammad Barakat^1*, Sofie-Katrin Kadel, MD^2*, Julia Mersi, MD^3*, Johannes Waldschmidt, MD¹, Hermann Einsele, MD¹, K. Martin Kortüm, MD^4*, Imad Maatouk, MD^1* and Leo Rasche, MD^5*

¹Department of Internal Medicine II, University Hospital Wuerzburg, Wuerzburg, Germany
²University Hospital of Würzburg, Würzburg, Germany
³Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany
⁴Department of Internal Medicine II, University Hospital of Würzburg, Wuerzburg, Germany
⁵Department of Internal Medicine II, University Hospital Wuerzburg, Wuerzburg, Bavaria, Germany

Ashley Rosko, MD¹, Don Benson, MD¹, Francesca Cottini, MD^1,2, Abdullah Mohammad Khan, MD, MBBS^1,3,4,5, Srinivas Devarakonda, MD^1,6,7, Elvira Umyarova, MD⁸, Naresh Bumma, MD^4,5,9, Lisa Blackburn^10*, Cathie Atkinson^11*, Juan Peng^12*, Janice Kiecolt-Glaser^13* and Lisa Christian^14*

¹The Ohio State University, Columbus, OH
²Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH
³US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS
⁴Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, OH
⁵The Ohio State University Comprehensive Cancer Center, Columbus, OH
⁶Division of Hematology, Department of Internal Medicine, Ohio State University Medical Center, Columbus, OH
⁷Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
⁸The Ohio State University Wexner Medical Center, Columbus, OH
⁹The Ohio State University, COLUMBUS, OH
¹⁰The Ohio State University, College of Medicine, Columbus
¹¹Institute for Behavioral Medicine Research, Ohio State University, Columbus, OH
¹²Depart of Medicine, Center for Biostatistics, Ohio State University, Columbus, OH
¹³Department of Medicine-Psychiatry, Ohio State University, Columbus, OH
¹⁴Depart of Medicine-Psychiatry, Ohio State University, Columbus, OH

Sita D. Bhella, MD¹, Allison M. Wilkin, PhD^2*, Katrina Hueniken^3*, Abi Vijenthira, MD, SM⁴, Michael Sebag, MD, PhD⁵, Peng Wang, MD, PhD^6*, Lisa K Hicks, MD⁷, Annette E. Hay, MD, FRCPath, FRCPC⁸, Arleigh McCurdy, MD⁹, Seyed Hosseini-Moghaddam^10*, Donna Reece, MD¹, Sarit E. Assouline, MD¹¹, Graeme Andrew McCrae Fraser, MD, MSc, FRCPC¹², Amaris K Balitsky, MD, MSc, FRCPC¹³, Joy Mangel, MD, FRCPC¹⁴, Carolyn Owen, MD, FRCPC¹⁵, Anthony Reiman, MD¹⁶, Laurie H. H. Sehn, MD¹⁷, Heather J. Sutherland, MD, PhD, FRCPC¹⁸, Corey Arnold^19*, Tamara Leite^20*, Erinn McCarthy^21*, Curtis Cooper^22*, Marc-Andre Langlois^23* and C. Arianne Buchan^24*

¹Princess Margaret Cancer Centre, Toronto, ON, Canada
²Ottawa Health Research Institute, Ottawa, ON, Canada
³Department of Biostatistics, University Health Network, Toronto, ON, Canada
⁴Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
⁵McGill University, Montréal, QC, Canada
⁶Department of Medicine, University of Alberta, Edmonton, AB, Canada
⁷Division of Hematology/Oncology, St. Michael's Hospital, Toronto, ON, Canada
⁸Division of Hematology, Department of Medicine, Queen's University, Kingston, ON, Canada
⁹The Ottawa Hospital, Ottawa, ON, Canada
¹⁰University Health Network/Toronto General Hospital, Toronto, ON, CAN
¹¹Jewish General Hospital, McGill University, Westmount, QC, Canada
¹²Department of Oncology, McMaster University, Hamilton, ON, Canada
¹³Juravinski Cancer Centre, Department of Oncology, McMaster University, Hamilton, Canada
¹⁴Department of Medicine, Division of Hematology, University of Western Ontario, London, ON, Canada
¹⁵Tom Baker Cancer Centre, Alberta Health Services, Calgary, AB, Canada
¹⁶Department of Oncology, Saint John Regional Hospital, Saint John, NB, Canada
¹⁷Division of Medical Oncology, University of British Columbia, Vancouver, BC, Canada
¹⁸Vancouver General Hospital, Vancouver, BC, Canada
¹⁹Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada
²⁰The Ottawa Hospital Research Institute (OHRI), Ottawa, Canada
²¹Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
²²Ottawa Hospital Research Institute, Ottawa, ON, Canada
²³University of Ottawa, Ottawa, ON, CAN
²⁴The University of Ottawa, Ottawa, Canada

George Mellgard, MD¹, Abdul-hamid Bazarbachi, MD^2*, Saurabh Zanwar, MD, MBBS³, Ute Hegenbart, MD^4*, Geethika Bodanapu, MD^5*, Divaya Bhutani, MD⁶, Guizhen Chen, MD^7*, Anita D'Souza, MD, MS^8*, Angela Dispenzieri, MD³, Morie A. Gertz, MD³, Shaji Kumar, MD³, Suzanne Lentzsch, MD, PhD², Paolo Milani, MD, PhD⁹, Eli Muchtar, MD³, Giovanni O. Palladini, MD, PhD¹⁰, Anannya Patwari, MD^8*, Vaishali Sanchorawala¹¹, Shikun Wang, PhD^12*, Stefan O. Schönland, MD^13*, Rajshekhar Chakraborty, MD⁶ and Andrew J. Cowan, MD¹⁴

¹Newyork-Presbyterian - Columbia University Irving Medicla Center, New York, NY
²Columbia University Herbert Irving Comprehensive Cancer Center, New York, NY
³Division of Hematology, Mayo Clinic, Rochester, MN
⁴Medical Department V, Amyloidosis Center, University of Heidelberg, Heidelberg, Germany
⁵Section of Hematology/Oncology, Boston University Medical Center, Boston, MA
⁶Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY
⁷Division of Medical Oncology, University of Washington, Seattle, WA
⁸Medical College of Wisconsin, Milwaukee, WI
⁹Amyloidosis Research and Treatment Center, Foundation "Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo," and Department of Molecular Medicine, University of Pavia, Pavia, Italy
¹⁰Amyloidosis Research and Treatment Center, Foundation "Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo," and Department of Molecular Medicine, University of Pavia, Pavia, PV, Italy
¹¹Section of Hematology and Medical Oncology, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA
¹²Herbert Irving Comprehensive Cancer Center and Columbia University Irving Medical Center, New York, NY
¹³Medical Department V, Amyloidosis Center,, University of Heidelberg, Heidelberg, Germany
¹⁴University of Washington, Seattle, WA

Ayobami Olafimihan, MBBS¹, Inimfon Jackson, MD, PhD, MPH², Ferdinand Ugwuja, MD^3*, Praise Fawehinmi^4* and Marwah Farooqui, DO⁵

¹John H. Stroger Jr. Hospital of Cook County, Chicago, IL
²The University of Texas MD Anderson Cancer Center, Houston, TX
³John H Stroger Jr. Hospital of Cook County, Chicago, IL
⁴Southern Illinois University Edwardsville, Edwardsville
⁵Hematology Oncology, University of Illinois, Burr Ridge, IL